Corporate TRANSACTIONAL

WilmerHale is widely recognized for its preeminence in the representation of technology and life sciences companies in the US and Europe. Our corporate lawyers are renowned for their work in initial public offerings, venture capital, mergers and acquisitions, strategic alliances, corporate governance matters and the representation of emerging companies.

Our business lawyers draw on the resources of our intellectual property, tax, labor and employment, employee benefits, litigation, real estate, bankruptcy and antitrust practices to provide a one-stop solution to our corporate clients.

Serving a diverse range of clients, from public and private companies to families and individual entrepreneurs, our corporate lawyers:

  • Served as issuer counsel or underwriters' counsel in more than 400 public offerings raising nearly $150 billion since 2004, including an issuer counsel in deals such as Yandex's $1.435 billion IPO, the largest IPO in history by a search engine company, and the IPOs of Accretive Health, Ameresco, Demandware, Merrimack Pharmaceuticals, SS&C Technologies, Tangoe, Verastem and WhiteWave Foods Company, among other recent IPOs
  • Acted as company counsel or investor counsel in more than 2,200 venture financings raising more than $20 billion since 2004, including multimillion-dollar financings by emerging leaders in life sciences, information technology, cleantech and other industries
  • Advised on more than 1,000 M&A deals valued in excess of $350 billion since 2004, including Thermo Fisher Scientific's $3.5 billion acquisition of Phadia and the sale of EqualLogic to Dell for $1.4 billion—the largest all-cash purchase price for a venture capital-backed company in history
  • Serve as outside corporate counsel for more than 100 public companies in the United States and Europe, advising them on critical securities, disclosure and corporate governance matters
  • Handle hundreds of strategic alliances, joint ventures, outsourcing and licensing transactions each year, including several strategic alliances that have received industry recognition for their importance
  • Have focused on startup companies and their special needs for decades, and have one of the top emerging company practices in the world
  • Represent venture, buyout and fund of fund complexes in their fund formation and ongoing administrative activities, including funds in the US, India, Europe and Asia

WilmerHale is widely recognized for its preeminence in the representation of technology and life sciences companies in the US and Europe. Our corporate lawyers are renowned for their work in initial public offerings, venture capital, mergers and acquisitions, strategic alliances, corporate governance matters and the representation of emerging companies.

Our business lawyers draw on the resources of our intellectual property, tax, labor and employment, employee benefits, litigation, real estate, bankruptcy and antitrust practices to provide a one-stop solution to our corporate clients.

Read More

Contacts

Sort By
Borden, Mark G.

Mark G. Borden

Chair, Corporate Practice Group

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Buckland, Peter

Peter Buckland

Vice Chair, Corporate Practice Group

Co-Chair, Emerging Company Practice

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Der Marderosian, Lia

Lia Der Marderosian

Vice Chair, Corporate Practice Group

Co-Chair, Life Sciences Group

+1 617 526 6982 (t)

lia.dermarderosian@wilmerhale.com

Evans, Stephanie C.

Stephanie C. Evans

Vice Chair, Corporate Practice Group

+1 202 663 6355 (t)

stephanie.evans@wilmerhale.com

Bain, Mick

Mick Bain

Partner

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Brown, Lillian

Lillian Brown

Partner

+1 202 663 6743 (t)

lillian.brown@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Experience

  • We handled more IPOs from 1996-2010 for eastern US companies than any other law firm in the country.
  • We handled more IPOs in 2004-2010 for eastern US technology companies than any other law firm in the country.
  • We handled more Rule 144A equity placements from 2001-2010 for eastern US companies than any other law firm in the country.
  • We handled more VC financings in 2009 for eastern US companies than any other law firm in the country.
  • We represent more eastern US VC-backed companies than any other law firm in the country.
  • We handled more VC financings in 2009 for European companies than any other law firm in Europe.
  • We represent more European VC-backed companies than any other law firm in Europe.
  • We handled more sales of eastern US VC-backed companies in 2009 than any other law firm in the country.
  • We handled more sales of eastern US VC-backed companies from 1996-2009 than any other law firm in the country.

We represent numerous market leaders in technology and life sciences, including:

  • Biopharmaceutical companies such as Bayer, Millennium Pharmaceuticals and Sepracor
  • Instrument and laboratory sciences companies such as PerkinElmer and Thermo Fisher Scientific
  • Software companies such as Amdocs, Avid and Red Hat
  • Semiconductor industry companies such as Analog Devices and Varian Semiconductor
  • Suppliers of computer storage and peripheral devices such as EMC and Iomega
  • Enablers of e-commerce such as Akamai Technologies and DoubleClick

We also represent leading companies in a wide variety of other industries, including manufacturers such as Danaher, retailers such as BJ’s and Staples, financial services providers such as Citigroup and Fannie Mae, consumer goods companies such as Bose and Saucony, television broadcasters such as LIN TV and Sinclair Broadcast Group, and professional sports leagues and franchises such as the NHL and the Baltimore Ravens.

Additional corporate experience: 2013, 20122011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003*, 2002*, 2001*

*Note: These overviews describe experience of Hale and Dorr lawyers prior to the merger of Hale and Dorr LLP and Wilmer Cutler Pickering LLP.

  

Publications & News

View

December 8, 2014

A Prescription for the New Massachusetts Sick Leave Law

On November 4, 2014, Massachusetts voters decisively approved a ballot question requiring employers to provide sick leave to employees, adding Massachusetts to a growing list of states (including Connecticut and California) and municipalities (including New York City, San Francisco and Seattle) requiring such leave.

November 17, 2014

Firm Co-Sponsors Equal Justice Works Fellowship

WilmerHale joined with firm client Staples to co-sponsor an Equal Justice Works fellowship, which provides the opportunity for lawyers to positively impact vulnerable communities across the United States.

November 17, 2014

CFPB Releases Long-Awaited Proposal on Prepaid Account Products

On November 13, 2014, the Consumer Financial Protection Bureau (“CFPB”) issued a proposed rule to extend certain federal consumer protections to the prepaid market.

November 17, 2014

Proposed Prepaid Rule Unlikely To Stem Growth

An article by Franca Harris Gutierrez, Bradford Hardin and Maury Riggan, published by Law360 on November 17, 2014.

November 4, 2014

U.S. News – Best Lawyers® Release 2015 “Best Law Firms” List, Names WilmerHale International Arbitration “Law Firm of the Year”

The 2015 U.S. News - Best Lawyers® "Best Law Firms" list includes WilmerHale being named a first-tier law firm in 24 national and 62 metro-area rankings. In addition, the firm boasts more than 20 second- and third-tier rankings in several national and metro-area rankings.

October 22, 2014

Progress Software Announces Intent to Acquire Telerik

WilmerHale client Progress Software Corporation announced that it has entered into a definitive agreement to acquire privately held Telerik AD, a leading provider of application development tools.

October 16, 2014

Stephanie Evans Recognized Among Diversity Journal's Women Worth Watching

Diversity Journal has recognized Partner Stephanie Evans to its 13th annual list of Women Worth Watching, which honors executive trailblazers for their passion, potential and positive influence both inside and outside the workplace.

October 9, 2014

SEC Enforcement Actions Emphasize Importance of Stock Ownership Reporting Obligations for Public Companies and Insiders

On September 10, 2014, the Securities and Exchange Commission announced charges against 28 officers, directors and major stockholders of public companies for violating Section 16(a) and/or Section 13(d) of the Securities Exchange Act of 1934, as amended.

October 8, 2014

Actavis to Acquire Durata Therapeutics, Inc.

On October 6, 2014, WilmerHale client Durata Therapeutics announced that it had entered into a definitive merger agreement with Actavis plc under which a subsidiary of Actavis will commence a tender offer to acquire all of the outstanding shares of Durata common stock.

October 7, 2014

Park Square, EY and WilmerHale Release 15th Annual Tech and Life Sciences Compensation and Entrepreneurship Study

According to an executive compensation study of private businesses released today, non-founder C-suite executives at life sciences and healthcare companies saw their cash compensation increase by 4.2 percent year-over-year, while comparable executives at private technology firms experienced an average increase of 3 percent.

Events

February 10, 2015

Practising Law Institute: Corporate Governance – A Master Class 2015

New York, New York

December 15, 2014

WilmerHale Life Sciences Webinar: Negotiating Companion Diagnostic Collaboration Agreements

Webinar

December 9, 2014

MIT $100K Accelerate – Seminar for Participants

Cambridge, Massachusetts

December 4-5, 2014

Annual Disclosure Documents 2014

Chicago, Illinois

December 1-2, 2014

Annual Disclosure Documents 2014

Webinar

November 19, 2014

Immigration Law Workshop: a Focus on Startups

Cambridge, Massachusetts

November 12, 2014

Center on Executive Compensation Annual Meeting

Washington, DC

November 11, 2014

Angel Bootcamp

Cambridge, Massachusetts

November 5-7, 2014

Practising Law Institute: 46th Annual Securities Regulation Institute

New York, New York

October 30, 2014

MCLE: 32nd Annual Business & Securities Law Conference 2014

Boston, Massachusetts

Recognition

  • Best Lawyers in America – Recognized nearly 100 WilmerHale partners, naming nine "Lawyer of the Year" for 2015, including Mark Borden as Boston Corporate Law "Lawyer of the Year" and Steve Singer as New York Mergers and Acquisitions "Lawyer of the Year"
  • BioPharm Insight – Ranked WilmerHale among the top law firms in 2011 and 2012 for licensing and M&A, and also among the top four firms for M&A deals globally based on volume
  • Boston Business Journal and Mass High Tech – Named WilmerHale to the 2013 "Innovation All-Stars" List, an annual program that recognizes outstanding companies and individuals "whose products and services help our Innovation economy thrive"
  • Chambers Asia Pacific – Recognized our Beijing corporate practice in 2013 with a ranking in the category of Corporate/M&A: Highly Regarded (International Firms)
  • Chambers Asia Pacific – Recognized our Beijing corporate practice in 2012 and 2013 with a top ranking in the category of Corporate/M&A: International Law (China)
  • Chambers Global – Named 35 lawyers among the "World's Leading Lawyers for Business" and recognized 13 of our practice areas, including Corporate/M&A in 2013. In 2012, Chambers Global named 29 lawyers among the "World's Leading Lawyers for Business" and recognized 12 of our practice areas, including Corporate/M&A.
  • Chambers USA: America's Leading Lawyers for Business – Named our corporate practice among the best in 2013 and 2014, with sources saying "for corporate and business development, they are at the top." Chambers also ranked WilmerHale in the following regions and practices: Nationwide Outsourcing; Massachusetts, New York and Washington DC Corporate/M&A; and Massachusetts Private Equity: Fund Formation, Private Equity: Venture Capital Investment and Technology.
  • Chambers USA: America's Leading Lawyers for Business – Recognized our corporate practice in 2012 as "superb" with "outstanding quality at all levels," and specifically acknowledged our Massachusetts and Washington DC private equity practice in the areas of fund formation and venture capital investments, and our Massachusetts and New York M&A practice
  • Chambers USA: America's Leading Lawyers for Business – Acknowledged our Boston M&A practice in 2009 with a first tier ranking, saying "this superb and sophisticated corporate firm, drew rave reviews from clients for its outstanding work, particularly in the life sciences and higher technology sectors." The Boston private equity: venture capital investment group also received a first tier ranking. Chambers notes that, "clients turn to the group for its virtually unmatched level of experience and trust it to meet all their needs."
  • Corporate Board Member – In 2014, WilmerHale was named to "America's Top Corporate Law Firms" list, a comprehensive ranking of the top 25 firms in the nation. Results are based on law firm surveys and feedback from thousands of directors and general counsels.
  • JUVE Handbook – A leading legal publication in Germany, named WilmerHale's Berlin and Frankfurt offices among its 2012/2013 and 2013/14 "Top 50" law firms in Germany, and highly recommended our corporate and mergers and acquisitions practices
  • Practical Law Company (PLC) – In the PLC Cross-border Life Sciences Handbook 2011/2012, WilmerHale is listed as a leading law firm, the highest ranking possible, in the US for life sciences in corporate. WilmerHale also earned a place among the top ten law firms in PLC's 2012 Life Sciences Industry Super League.
  • Practical Law Company (PLC) – In the PLC Private Equity/Venture Capital Handbook 2009/10 recognized WilmerHale as a leading law firm in the areas of private equity and venture capital. The firm was listed as "leading," the highest ranking possible in Fund Formation and Venture Capital. PLC individually recognized Sarah Rothermel in the fund formation category and Mark Borden and Michael Bain in the venture capital category.
  • Recombinant Capital – In four of the last eight years, WilmerHale worked on the biotech strategic alliance which was chosen for the Breakthrough Alliance Award
  • Super Lawyers – Twenty-one of our Massachusetts-based corporate lawyers were recognized in Boston Magazine's 2008 issue as "Massachusetts Super Lawyers"
  • The Legal 500 EMEA – Recommended WilmerHale's Brussels, Berlin and Frankfurt offices in 10 practice areas, including corporate and M&A in 2012 and 2013
  • The Legal 500 UK – Recommended WilmerHale's London offices in their 2013 edition in 10 practice areas, including corporate and commercial: financial services; corporate and commercial: M&A; and corporate and human resources: employee share schemes
  • The Legal 500 United States – Recommended WilmerHale's mergers and acquisitions practice in the areas of antitrust, M&A middle-market, and venture capital and emerging companies in their 2010, 2011, 2012 and 2013 editions
  • U.S. News - Best Lawyers® – In the 2010-2015 "Best Law Firms" rankings, our corporate law, mergers and acquisitions and venture capital law practices were ranked in the first-tier nationally and in Boston, New York and Washington DC. Our technology law practice was also ranked in the first-tier nationally and in Boston.

2014 Reports

WilmerHale’s annual IPO, Venture Capital and M&A Reports provide comprehensive statistics and analysis that are hard to find elsewhere.

Our 2014 IPO Report offers a detailed analysis of, and outlook for, the IPO market. The report features regional breakdowns; useful IPO market metrics; an update on the pros, cons and recent rates of adoption of various elements of JOBS Act relief available to emerging growth companies; and a look at the expanded role CEOs now must play in the IPO process. We review important considerations around the inclusion of “flash results” in IPO prospectuses; present a primer on the characteristics of venture capital–backed and private equity–backed IPOs; and provide an overview of “cross-border” IPOs by foreign companies in the United States.

The 2014 Venture Capital Report offers an in-depth analysis of, and outlook for, the US and European venture capital markets. The report features industry and regional breakdowns, an analysis of trends in venture capital financing and VC-backed company M&A deal terms, and a look at important considerations for startups in light of JOBS Act provisions that loosen restrictions around general solicitation and crowdfunding.

Our 2014 M&A Report contains a detailed review of, and outlook for, the global M&A market. Other highlights include a comparison of deal terms in public and private acquisitions, an update on takeover defenses, and insights into CFIUS and FCPA considerations in M&A transactions. We also look at financial statement requirements in mergers and acquisitions, and survey key terms in sales of VC-backed companies.

Each report also includes a center spread showcasing prominent recent transactions in each area and company counsel rankings from independent sources showing WilmerHale’s preeminence as counsel in IPOs, VC financings and sales of VC-backed companies.

To request a hard copy of any of the reports, contact the WilmerHale Marketing Department at WHCorporateReports@wilmerhale.com or call +1 617 526 5600.